TickerFacts.

Bausch & Lomb Corp (BLCO): Operating Income

Annual figures by period end, from SEC filings.

$113.00M
Year ended 2025-12-31
$323.00M
Trailing 12 months to 2026-06-30
-18.3%
3-year compound annual growth
-15.4%
5-year compound annual growth
$329.00M2020-12-31: $260.00M2021-12-31: $329.00M2022-12-31: $207.00M2023-12-31: $130.00M2024-12-31: $162.00M2025-12-31: $113.00M$113.00M
2020-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$113.00M-30.2%2026-02-18, From 2025-01-01
2024-12-31$162.00M+24.6%2026-02-18, From 2024-01-01
2023-12-31$130.00M-37.2%2026-02-18, From 2023-01-01
2022-12-31$207.00M-37.1%2025-02-19, From 2022-01-01
2021-12-31$329.00M+26.5%2024-02-21, From 2021-01-01
2020-12-31$260.00Mn/a2023-02-22, From 2020-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Ophthalmic Goods), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Bausch & Lomb Corp (BLCO)2025-12-31$113.00M-30.2%
Cooper Companies, Inc. (COO)2025-10-31$682.90M-3.2%
National Vision Holdings, Inc. (EYE)2026-01-03$58.83Mn/m
Warby Parker Inc. (WRBY)2025-12-31-$5.34Mn/m
Staar Surgical Co (STAA)2026-01-02-$91.71Mn/m
RxSight, Inc. (RXST)2025-12-31-$48.19Mn/m

Compare BLCO, COO, EYE, WRBY side by side · Screen every company in Ophthalmic Goods ↗